Pharmaresearch Q2 Operating Profit Forecast at 70 Billion Won on Export Growth
Pharmaresearch is accelerating overseas market expansion based on its competitive strength in the domestic Rejuran market. Samsung Securities forecasts the company's Q2 revenue will reach 172.5 billion won, up 22.6% year-over-year, and operating profit will increase 25.3% to 70 billion won,
PharmaResearch-2.72%
LucasBennett·07-17 08:21
